Sana Biotechnology, Inc. (SANA)
SANA Stock Price Chart
Explore Sana Biotechnology, Inc. interactive price chart. Choose custom timeframes to analyze SANA price movements and trends.
SANA Company Profile
Discover essential business fundamentals and corporate details for Sana Biotechnology, Inc. (SANA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Feb 2021
Employees
194.00
Website
https://www.sana.comCEO
Steven D. Harr
Description
Sana Biotechnology, Inc. is a biotechnology firm focused on creating treatments using engineered cells. The company develops advanced ex vivo and in vivo cell engineering platforms to address a range of conditions with significant unmet medical needs, including various cancers, diabetes, central nervous system disorders, cardiovascular diseases, and genetic illnesses. Its portfolio of drug candidates includes SG295 and SG242, which are designed to target CD19+ cancer cells involved in non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia. For multiple myeloma, Sana is progressing SG221, SG239, and SC255. Other pipeline assets include SG328 for ornithine transcarbamylase deficiency, and SG418 for sickle cell disease and beta-thalassemia. Additionally, the company is advancing SC291, a CD19 allogeneic T cell therapy, SC451 for type I diabetes mellitus, and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Founded in 2018 as FD Therapeutics, Inc., the company adopted its current name, Sana Biotechnology, Inc., in September 2018 and is based in Seattle, Washington.
SANA Financial Timeline
Browse a chronological timeline of Sana Biotechnology, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Aug 2026
EPS estimate is -$0.15.
Earnings released on 11 May 2026
EPS came in at -$0.14 surpassing the estimated -$0.15 by +6.67%.
Earnings released on 3 Mar 2026
EPS came in at -$0.16 falling short of the estimated -$0.13 by -23.08%.
Earnings released on 6 Nov 2025
EPS came in at -$0.15 surpassing the estimated -$0.18 by +16.67%.
Earnings released on 11 Aug 2025
EPS came in at -$0.16 surpassing the estimated -$0.20 by +20.00%.
Earnings released on 8 May 2025
EPS came in at -$0.20 surpassing the estimated -$0.22 by +9.09%.
Earnings released on 17 Mar 2025
EPS came in at -$0.23 surpassing the estimated -$0.25 by +8.00%.
Earnings released on 8 Nov 2024
EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%.
Earnings released on 8 Aug 2024
EPS came in at -$0.32 falling short of the estimated -$0.27 by -18.52%.
Earnings released on 8 May 2024
EPS came in at -$0.32 falling short of the estimated -$0.30 by -6.67%.
Earnings released on 29 Feb 2024
EPS came in at -$0.35 surpassing the estimated -$0.37 by +5.41%.
Earnings released on 8 Nov 2023
EPS came in at -$0.41 surpassing the estimated -$0.42 by +2.38%.
Earnings released on 3 Aug 2023
EPS came in at -$0.45 falling short of the estimated -$0.42 by -7.14%.
Earnings released on 8 May 2023
EPS came in at -$0.43 falling short of the estimated -$0.38 by -13.16%.
Earnings released on 16 Mar 2023
EPS came in at -$0.40 surpassing the estimated -$0.41 by +2.44%.
Earnings released on 2 Nov 2022
EPS came in at -$0.48 falling short of the estimated -$0.39 by -23.08%.
Earnings released on 4 Aug 2022
EPS came in at -$0.47 falling short of the estimated -$0.46 by -2.17%.
Earnings released on 10 May 2022
EPS came in at -$0.47 falling short of the estimated -$0.38 by -23.68%.
Earnings released on 16 Mar 2022
EPS came in at -$0.65 falling short of the estimated $0.36 by -280.56%.
Earnings released on 8 Nov 2021
EPS came in at -$0.37 falling short of the estimated -$0.29 by -27.59%.
Earnings released on 4 Aug 2021
EPS came in at -$0.32 surpassing the estimated -$0.37 by +13.51%.
SANA Stock Performance
Access detailed SANA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
